SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-17-004339
Filing Date
2017-01-27
Accepted
2017-01-27 16:44:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v457735_sc13d-a.htm SC 13D/A 45312
  Complete submission text file 0001144204-17-004339.txt   46755
Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address
ROSENWALD LINDSAY A MD (Filed by) CIK: 0000941841 (see all company filings)

Type: SC 13D/A

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Subject) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86661 | Film No.: 17554327
SIC: 2834 Pharmaceutical Preparations